IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Recruiting · NCT03152058 · Registry updated 2026-04-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy | Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, pregnancy disorder | Recruiting | Phase 2 | 2026-04-01 | NCT03152058 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| David Ware Branch | 1 |
| Hospital for Special Surgery, New York | 71 |
| NYU Langone Health | 359 |
| University of Toronto | 140 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital for Special Surgery | New York | United States | 106 |
| TRIO Advancing Reproductive Care | Toronto | Canada | 1 |
| University of Utah | Salt Lake City | United States | 106 |